Target intelligence / Profile preview

Synaptotagmin 14 pseudogene 1 (SYT14P1)

Target
SYT14P1
Molecular classification
Other (pseudogene)
01

Overview

SYT14P1, or Synaptotagmin 14 pseudogene 1, is classified as a pseudogene that is similar in sequence to the protein-coding gene Synaptotagmin 14 (SYT14) but does not code for a functional protein. Pseudogenes such as SYT14P1 generally arise from duplication or retrotransposition events and typically lack known biological function or disease association. SYT14P1 has several alternative names, and there is a functional, protein-coding SYT14 gene, but SYT14P1 itself is not considered a therapeutic target and does not serve as a receptor, enzyme, transporter, or other actionable molecular entity in biomedical research or drug development. Most available data and clinical relevance (including associations with spinocerebellar ataxia) pertain to the functional SYT14 gene, not SYT14P1. For SYT14P1, there are no established biological functions, disease roles, or drug interactions. If information was intended for the protein-coding synaptotagmin 14 (SYT14), that target would have a distinct canonical name and profile.

Other names
Putative synaptotagmin-14-like proteinSYT14P1SYT14LSYT14LP1SYTDEPCHR415SYTSynaptotagmin XIV protein pseudogene 1Synaptotagmin XIV-derived proteinSynaptotagmin XIV-like protein

Beyond the preview

Go deeper on Synaptotagmin 14 pseudogene 1 (SYT14P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptotagmin 14 pseudogene 1 (SYT14P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call